Trial
NCT04338126
Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
COVID19
Intervention
Tranexamic acid
Why stopped
Due to ongoing vaccination efforts, feasibility for recruitment is low
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-23